Annual Cash & Cash Equivalents
$100.96 M
-$7.93 M-7.28%
December 31, 2023
Summary
- As of February 26, 2025, MGNX annual cash & cash equivalents is $100.96 million, with the most recent change of -$7.93 million (-7.28%) on December 31, 2023.
- During the last 3 years, MGNX annual cash & cash equivalents has fallen by -$80.17 million (-44.26%).
- MGNX annual cash & cash equivalents is now -54.14% below its all-time high of $220.13 million, reached on December 31, 2018.
Performance
MGNX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$179.63 M
+$95.69 M+114.01%
September 30, 2024
Summary
- As of February 26, 2025, MGNX quarterly cash and cash equivalents is $179.63 million, with the most recent change of +$95.69 million (+114.01%) on September 30, 2024.
- Over the past year, MGNX quarterly cash and cash equivalents has stayed the same.
- MGNX quarterly cash and cash equivalents is now -50.89% below its all-time high of $365.77 million, reached on September 30, 2015.
Performance
MGNX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MGNX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.3% | 0.0% |
| 3 y3 years | -44.3% | +279.5% |
| 5 y5 years | -54.1% | +279.5% |
MGNX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.2% | at low | -19.9% | +736.7% |
| 5 y | 5-year | -44.3% | at low | -19.9% | +736.7% |
| alltime | all time | -54.1% | +111.5% | -50.9% | +736.7% |
MacroGenics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $179.63 M(+114.0%) |
| Jun 2024 | - | $83.93 M(+4.5%) |
| Mar 2024 | - | $80.36 M(-20.4%) |
| Dec 2023 | $100.96 M(-7.3%) | $100.96 M(+12.3%) |
| Sep 2023 | - | $89.90 M(-17.3%) |
| Jun 2023 | - | $108.76 M(-51.5%) |
| Mar 2023 | - | $224.26 M(+106.0%) |
| Dec 2022 | $108.88 M(-11.8%) | $108.88 M(+29.6%) |
| Sep 2022 | - | $83.99 M(+291.2%) |
| Jun 2022 | - | $21.47 M(-54.6%) |
| Mar 2022 | - | $47.33 M(-61.7%) |
| Dec 2021 | $123.47 M(-31.8%) | $123.47 M(-35.2%) |
| Sep 2021 | - | $190.53 M(+0.8%) |
| Jun 2021 | - | $188.97 M(-13.5%) |
| Mar 2021 | - | $218.50 M(+20.6%) |
| Dec 2020 | $181.13 M(+43.2%) | $181.13 M(-10.2%) |
| Sep 2020 | - | $201.64 M(+2.6%) |
| Jun 2020 | - | $196.53 M(+111.2%) |
| Mar 2020 | - | $93.06 M(-26.4%) |
| Dec 2019 | $126.47 M(-42.5%) | $126.47 M(-19.2%) |
| Sep 2019 | - | $156.59 M(-13.2%) |
| Jun 2019 | - | $180.32 M(-24.4%) |
| Mar 2019 | - | $238.64 M(+8.4%) |
| Dec 2018 | $220.13 M | $220.13 M(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $201.81 M(-15.4%) |
| Jun 2018 | - | $238.66 M(+19.1%) |
| Mar 2018 | - | $200.45 M(-5.3%) |
| Dec 2017 | $211.73 M(+151.8%) | $211.73 M(+133.0%) |
| Sep 2017 | - | $90.88 M(-22.1%) |
| Jun 2017 | - | $116.63 M(+187.8%) |
| Mar 2017 | - | $40.52 M(-51.8%) |
| Dec 2016 | $84.10 M(-57.1%) | $84.10 M(-23.5%) |
| Sep 2016 | - | $109.90 M(+76.5%) |
| Jun 2016 | - | $62.27 M(-59.0%) |
| Mar 2016 | - | $151.95 M(-22.5%) |
| Dec 2015 | $196.17 M(+24.5%) | $196.17 M(-46.4%) |
| Sep 2015 | - | $365.77 M(+55.6%) |
| Jun 2015 | - | $235.03 M(-10.7%) |
| Mar 2015 | - | $263.13 M(+67.0%) |
| Dec 2014 | $157.59 M(+35.3%) | $157.59 M(-12.1%) |
| Sep 2014 | - | $179.19 M(-7.6%) |
| Jun 2014 | - | $194.01 M(-2.4%) |
| Mar 2014 | - | $198.72 M(+70.6%) |
| Dec 2013 | $116.48 M(+144.0%) | $116.48 M(+247.0%) |
| Sep 2013 | - | $33.57 M(-0.6%) |
| Jun 2013 | - | $33.78 M(-29.2%) |
| Dec 2012 | $47.74 M(-13.5%) | $47.74 M |
| Dec 2011 | $55.22 M | - |
FAQ
- What is MacroGenics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MacroGenics?
- What is MacroGenics annual cash & cash equivalents year-on-year change?
- What is MacroGenics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MacroGenics?
- What is MacroGenics quarterly cash and cash equivalents year-on-year change?
What is MacroGenics annual cash & cash equivalents?
The current annual cash & cash equivalents of MGNX is $100.96 M
What is the all time high annual cash & cash equivalents for MacroGenics?
MacroGenics all-time high annual cash & cash equivalents is $220.13 M
What is MacroGenics annual cash & cash equivalents year-on-year change?
Over the past year, MGNX annual cash & cash equivalents has changed by -$7.93 M (-7.28%)
What is MacroGenics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MGNX is $179.63 M
What is the all time high quarterly cash and cash equivalents for MacroGenics?
MacroGenics all-time high quarterly cash and cash equivalents is $365.77 M
What is MacroGenics quarterly cash and cash equivalents year-on-year change?
Over the past year, MGNX quarterly cash and cash equivalents has changed by $0.00 (0.00%)